Abizadeh, E.; Berglas, E.; Abizadeh, A.; Glatman, J.; Lavi, A.B.; Spivak, M.; Sapir, T.; Shifteh, D.
Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer. Int. J. Mol. Sci. 2025, 26, 8696.
https://doi.org/10.3390/ijms26178696
AMA Style
Abizadeh E, Berglas E, Abizadeh A, Glatman J, Lavi AB, Spivak M, Sapir T, Shifteh D.
Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer. International Journal of Molecular Sciences. 2025; 26(17):8696.
https://doi.org/10.3390/ijms26178696
Chicago/Turabian Style
Abizadeh, Ethan, Eli Berglas, Aaron Abizadeh, Julia Glatman, Aaron B. Lavi, Mark Spivak, Tzuriel Sapir, and David Shifteh.
2025. "Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer" International Journal of Molecular Sciences 26, no. 17: 8696.
https://doi.org/10.3390/ijms26178696
APA Style
Abizadeh, E., Berglas, E., Abizadeh, A., Glatman, J., Lavi, A. B., Spivak, M., Sapir, T., & Shifteh, D.
(2025). Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer. International Journal of Molecular Sciences, 26(17), 8696.
https://doi.org/10.3390/ijms26178696
